Shinomiya Hitomi, Otsuki Naoki, Yamashita Daisuke, Nibu Ken-Ichi
Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Auris Nasus Larynx. 2016 Aug;43(4):446-50. doi: 10.1016/j.anl.2015.11.002. Epub 2015 Dec 4.
To define the incidence and pattern of spread of lymph node metastasis from parotid cancers and to clarify the risk factors and appropriate extent of neck dissection (ND) for individual patient with parotid cancer.
A total of 72 patients with parotid gland cancer treated by surgery between 1994 and 2013 were analyzed retrospectively by reference to medical records. In line with our protocol, patients with clinically positive lymph nodes and/or cT3/T4 disease were generally selected to undergo ND.
Pathological examinations revealed mucoepidermoid carcinoma in 23 patients, carcinoma ex pleomorphic adenoma in 11, adenoid cystic carcinoma in 9, salivary duct carcinoma in 9, acinic cell carcinoma in 8, squamous cell carcinoma in 5, adenocarcinoma NOS in 4, epithelial myoepithelial carcinoma in 2, and basal cell carcinoma in 1. Thirty-three patients underwent neck dissection: modified radical ND (MRND) in 13, and elective ND (END) in 20. Postoperative RT (PORT) was performed in 33 patients. Among 13 cN+ patients, 10 were pN+ and lymph node metastasis was distributed mainly in levels I, II, III and V. Among 59 cN- patients, clinical T1, T2, T3 and T4 classifications accounted for 10, 24, 10 and 15 patients, respectively. The incidence of occult lymph node metastasis was 22%. Occult lymph node metastasis was mostly seen in the intraparotid, levels I and II of patients with cT4 disease. Among the ND group, 12 necks were pathologically negative for cancer (pN0). Relapse of neck lymph node metastasis occurred only in two patients treated by MRND with pathologically positive lymph nodes (pN+). These patients developed local and distant metastasis within 1 year after neck lymph node recurrence, and subsequently died of the cancer. pN+ was found in 19/30 high grade (63%), 1/10 intermediate grade (10%), and 3/32 low grade (9.4%). Among 33 patients who received PORT, only 1 patient relapsed neck lymph node.
For patients with clinically positive lymph nodes, ipsilateral modified radical neck dissection (levels I-V) is recommended. Elective neck dissection is strongly recommended for patients with T3N0 or T4N0 disease, and the extent of ND should include at least level I/II. PORT for patients with high-risk features may improve the outcome of good neck control.
明确腮腺癌淋巴结转移的发生率及转移模式,阐明腮腺癌个体患者颈部清扫术(ND)的危险因素及合适范围。
回顾性分析1994年至2013年间接受手术治疗的72例腮腺癌患者的病历。按照我们的方案,临床淋巴结阳性和/或cT3/T4期疾病的患者一般选择行颈部清扫术。
病理检查显示,黏液表皮样癌23例,多形性腺瘤癌变11例,腺样囊性癌9例,涎腺导管癌9例,腺泡细胞癌8例,鳞状细胞癌5例,非特殊类型腺癌4例,上皮-肌上皮癌2例,基底细胞癌1例。33例患者接受了颈部清扫术:13例行改良根治性颈部清扫术(MRND),20例行择区性颈部清扫术(END)。33例患者接受了术后放疗(PORT)。13例cN+患者中,10例为pN+,淋巴结转移主要分布在Ⅰ、Ⅱ、Ⅲ和Ⅴ区。59例cN-患者中,临床T1、T2、T3和T4分期分别占10、24、10和15例。隐匿性淋巴结转移的发生率为22%。隐匿性淋巴结转移多见于cT4期患者的腮腺内、Ⅰ区和Ⅱ区。在颈部清扫术组中,12例颈部病理检查未发现癌转移(pN0)。颈部淋巴结转移复发仅发生在2例行MRND且病理淋巴结阳性(pN+)的患者中。这些患者在颈部淋巴结复发后1年内发生局部和远处转移,随后死于癌症。19/30例高级别患者(63%)、1/10例中级别患者(10%)和3/32例低级别患者(9.4%)为pN+。在33例接受PORT的患者中,仅1例颈部淋巴结复发。
对于临床淋巴结阳性的患者,建议行同侧改良根治性颈部清扫术(Ⅰ-Ⅴ区)。对于T3N0或T4N0期疾病的患者,强烈建议行择区性颈部清扫术,颈部清扫范围应至少包括Ⅰ/Ⅱ区。具有高危特征的患者接受PORT可能改善颈部良好控制的结局。